Audrey Andrews

Authored Items

Suboptimal Dosing of Filgrastim is Acceptable for Treatment of Chemotherapy-Induced Neutropenia

Audrey Andrews

TON - May 2018, Vol 11, No 2 in Side-Effects Management

Palliative Care Specialists Want More Involvement

Audrey Andrews

TON July 2016 Vol 9 No 4 in Conference Correspondent

Managing Dermatologic Toxicities

Audrey Andrews

TON May 2015 Vol 8 No 3 in Best Practices

Maximizing Efficacy in the Infusion Unit: Making Patients and Nurses Happy

Audrey Andrews

TON May 2015 Vol 8 No 3 in Best Practices

Sorafenib Effective in Metastatic Differentiated Thyroid Cancer

Audrey Andrews

TON - August 2013 Vol 6 No 7 in Rare Cancers

NCCN Updates Its Clinical Practice Guidelines

Audrey Andrews

TON - July 2013 Vol 6 No 6 in Best Practices

The Changing Oncology Landscape: Evolution or Revolution?

Audrey Andrews

TON - July 2013 Vol 6 No 6 in Conference Correspondent

Distress Screening Should Be Integrated Into Routine Cancer Care

Audrey Andrews

TON - April 2013, Vol 6, No 3 in Conference Correspondent

Enhancing Communication in the Advanced-Disease Setting

Audrey Andrews

TON - April 2013, Vol 6, No 3 in Conference Correspondent

Home-Based TPN of Little Benefit in Terminally Ill Patients With GI Cancer

Audrey Andrews, Caroline Helwick

TON - March 2013, Vol 6, No 2 in Supportive Care, Supportive Care

Evidence Lacking for Eliminating Prophylactic Platelet Transfusions

Audrey Andrews

TON - March 2013, Vol 6, No 2 in Supportive Care

Peripheral Arterial Disease Seen With Nilotinib

Audrey Andrews

TON - March 2013, Vol 6, No 2 in Supportive Care

No Increase in Leukemia or Myelodysplastic Syndrome With Adjuvant Chemotherapy for Breast Cancer

Audrey Andrews

TON - November 2012, Vol 5, No 10 in Breast Cancer

Crizotinib Superior to Chemotherapy in First Head-to-Head Comparison

Audrey Andrews

TON - November 2012, Vol 5, No 10 in Lung Cancer

Regional Lymph Node Irradiation Indicated for Early Breast Cancer

Audrey Andrews

TON - October 2011 Vol 4 No 7 in Breast Cancer

Prolonged Treatment with Imatinib Recommended for High-Risk GIST

Audrey Andrews

TON - September 2011 Vol 4, No 6 in Conference Correspondent

Exemestane: A Promising New Option for Primary Prevention of Breast Cancer

Audrey Andrews

Online First in Conference Correspondent

Bevacizumab in Ovarian Cancer: More Support for Maintenance

Audrey Andrews

Online First in Conference Correspondent

Novel Agents Improve Survival in Metastatic Melanoma

Audrey Andrews

Online First in Conference Correspondent

PARP Inhibitor Prolongs Progression-Free Survival in Ovarian Cancer

Audrey Andrews

Online First in Conference Correspondent

NCCN Helps Guide Optimal Use of Myeloid Growth Factors for Prevention of Neutropenia

Audrey Andrews

Online First in Supportive Care

Hepatitis B Screening and Chemotherapy

Audrey Andrews

TON - June 2011, Vol 4, No 4 in Supportive Care

NCCN Helps Guide Optimal Use of Myeloid Growth Factors for Prevention of Neutropenia

Audrey Andrews

TON - Daily

Hepatitis B Screening and Chemotherapy

Audrey Andrews

TON - Daily

NCCN Updates Treatment Guidelines

Audrey Andrews

TON - March/April 2011, VOL 4, NO 2

Last modified: December 11, 2015